Literature DB >> 33106998

Downregulation of N-myc Interactor Promotes Cervical Cancer Cells Growth by Activating Stat3 Signaling.

Songbin Wu1,2,3, Xiaotian Li1, Huizi Chai1, Linyuan Feng1, Wenjing Li1, Hongjian Li4.   

Abstract

N-myc interactor (NMI), a member of the oncogene Myc family, has been reported to be closely related to the development of cancer. However, the character of NMI in cervical carcinoma has not been reported. Herein, we found that downregulation of NMI protein not only promoted the proliferation, migration, and invasion of HeLa cells, but also decreased their expression of Caspase-3 and Caspase-9. Silencing NMI promotes the epithelial-mesenchymal transition of human cervical carcinoma HeLa cells by upregulating N-cadherin, vimentin, and downregulating E-cadherin. Further investigation illustrated the downregulation of NMI can activate the STAT3 signaling pathway. In conclusion, we found that the downregulation of NMI plays an important role in the progression of cervical cancer, and may served as a novel therapeutic target for cervical cancer.

Entities:  

Keywords:  Apoptosis; EMT; NMI; Proliferation; Stat3 signaling pathway

Mesh:

Substances:

Year:  2020        PMID: 33106998     DOI: 10.1007/s12013-020-00943-0

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  2 in total

1.  SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells.

Authors:  L-L Huang; W Rao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-07       Impact factor: 3.507

2.  Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.

Authors:  Ryota Kondo; Kousuke Ishino; Ryuichi Wada; Hideyuki Takata; Wei-Xia Peng; Mitsuhiro Kudo; Shoko Kure; Yohei Kaneya; Nobuhiko Taniai; Hiroshi Yoshida; Zenya Naito
Journal:  Int J Oncol       Date:  2019-02-04       Impact factor: 5.650

  2 in total
  1 in total

1.  Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors.

Authors:  Heba Allah M Alsheikh; Brandon J Metge; Hawley C Pruitt; Sarah C Kammerud; Dongquan Chen; Shi Wei; Lalita A Shevde; Rajeev S Samant
Journal:  Oncogenesis       Date:  2021-06-02       Impact factor: 7.485

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.